Literature DB >> 19081579

Increased serum neurotrophin-4/5 levels in bipolar disorder.

Julio C Walz1, Pedro V Magalhães, Larriany M Giglio, Angelo B Cunha, Laura Stertz, Gabriel R Fries, Ana C Andreazza, Flávio Kapczinski.   

Abstract

Neurotrophins are central to several aspects of central nervous system function, and emerging evidence links these growth factors to mood disorders. The purpose of this study was to investigate serum neurotrophin-4/5 (NT-4/5) levels in patients with bipolar disorder, both within mood episodes and in euthymia. Patients with bipolar I disorder (n=154) and controls (n=30) had their NT-4/5 serum levels assayed using an ELISA. Levels of NT-4/5 levels were significantly higher in bipolar disorder patients than in controls; NT-4/5 levels were increased in mania, depression and euthymia, but not significantly different between BD mood states. As far as are aware, this is the first study showing NT-4/5 immunocontent alterations in bipolar disorder. A tentative explanation would be that NT-4/5 increases is compensating for ongoing oxidative damage in dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081579     DOI: 10.1016/j.jpsychires.2008.10.005

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  12 in total

Review 1.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 2.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder.

Authors:  Joel Jakobsson; Mats Stridsberg; Henrik Zetterberg; Kaj Blennow; Carl-Johan Ekman; Anette G M Johansson; Carl Sellgren; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

4.  The role of BDNF as a mediator of neuroplasticity in bipolar disorder.

Authors:  Iria Grande; Gabriel Rodrigo Fries; Mauricio Kunz; Flavio Kapczinski
Journal:  Psychiatry Investig       Date:  2010-12-15       Impact factor: 2.505

Review 5.  The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections.

Authors:  Andrea László; Lilla Lénárt; Lilla Illésy; Andrea Fekete; János Nemcsik
Journal:  J Neural Transm (Vienna)       Date:  2019-02-14       Impact factor: 3.575

6.  Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.

Authors:  Tobias Rowland; Benjamin I Perry; Rachel Upthegrove; Nicholas Barnes; Jayanta Chatterjee; Daniel Gallacher; Steven Marwaha
Journal:  Br J Psychiatry       Date:  2018-09       Impact factor: 9.319

7.  Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed mice.

Authors:  Narumi Hashikawa-Hobara; Takumi Ogawa; Yusuke Sakamoto; Yumi Matsuo; Mami Ogawa; Yoshito Zamami; Naoya Hashikawa
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

8.  Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study.

Authors:  Anne-Laure Fauchais; Marie-Claude Lise; Pierre Marget; François-Xavier Lapeybie; Holy Bezanahary; Clothilde Martel; Stéphanie Dumonteil; Agnès Sparsa; Fabrice Lalloué; Kim Ly; Marie Essig; Elisabeth Vidal; Marie-Odile Jauberteau
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

9.  Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition.

Authors:  Cristina Gonzalez-Liencres; Cumhur Tas; Elliot C Brown; Soner Erdin; Ece Onur; Zeynep Cubukcoglu; Omer Aydemir; Aysen Esen-Danaci; Martin Brüne
Journal:  BMC Psychiatry       Date:  2014-09-24       Impact factor: 3.630

10.  Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients.

Authors:  Neveen E Sorour; Fatma M Elesawy; Hala A Tabl; Mohammed E Ibrahim; Essam M Akl
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.